Research priorities in spasmodic dysphonia
- PMID: 18922334
- PMCID: PMC2643054
- DOI: 10.1016/j.otohns.2008.05.624
Research priorities in spasmodic dysphonia
Abstract
Objective: To identify research priorities to increase understanding of the pathogenesis, diagnosis, and improved treatment of spasmodic dysphonia.
Study design and setting: A multidisciplinary working group was formed that included both scientists and clinicians from multiple disciplines (otolaryngology, neurology, speech pathology, genetics, and neuroscience) to review currently available information on spasmodic dysphonia and to identify research priorities.
Results: Operational definitions for spasmodic dysphonia at different levels of certainty were recommended for diagnosis and recommendations made for a multicenter multidisciplinary validation study.
Conclusions: The highest priority is to characterize the disorder and identify risk factors that may contribute to its onset. Future research should compare and contrast spasmodic dysphonia with other forms of focal dystonia. Development of animal models is recommended to explore hypotheses related to pathogenesis. Improved understanding of the pathophysiology of spasmodic dysphonia should provide the basis for developing new treatment options and exploratory clinical trials.
Significance: This document should foster future research to improve the care of patients with this chronic debilitating voice and speech disorder by otolaryngology, neurology, and speech pathology.
Figures


Similar articles
-
Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.Ann Otol Rhinol Laryngol. 2003 Jun;112(6):499-505. doi: 10.1177/000348940311200603. Ann Otol Rhinol Laryngol. 2003. PMID: 12834116
-
Recurrent layngeal nerve section for spasmodic dysphonia.Ann Otol Rhinol Laryngol. 1979 Jul-Aug;88(4 Pt 1):527-30. doi: 10.1177/000348947908800414. Ann Otol Rhinol Laryngol. 1979. PMID: 475250
-
Botox treatment in adductor spasmodic dysphonia: a meta-analysis.J Speech Lang Hear Res. 2002 Jun;45(3):469-81. doi: 10.1044/1092-4388(2002/037). J Speech Lang Hear Res. 2002. PMID: 12069000
-
Vocal aging and adductor spasmodic dysphonia: response to botulinum toxin injection.Clin Interv Aging. 2008;3(1):131-51. doi: 10.2147/cia.s1416. Clin Interv Aging. 2008. PMID: 18488884 Free PMC article. Review.
-
Spasmodic Dysphonia: A Review. Part 2: Characterization of Pathophysiology.Otolaryngol Head Neck Surg. 2017 Oct;157(4):558-564. doi: 10.1177/0194599817728465. Epub 2017 Aug 29. Otolaryngol Head Neck Surg. 2017. PMID: 28850796 Review.
Cited by
-
Non-aesthetic uses of botulinum toxin in the head and neck.Eur Arch Otorhinolaryngol. 2021 Nov;278(11):4147-4154. doi: 10.1007/s00405-021-06750-4. Epub 2021 Mar 18. Eur Arch Otorhinolaryngol. 2021. PMID: 33738565 Review.
-
Symptom Expression Across Voiced Speech Sounds in Adductor Laryngeal Dystonia.J Voice. 2025 Mar;39(2):567.e23-567.e30. doi: 10.1016/j.jvoice.2022.10.002. Epub 2022 Nov 21. J Voice. 2025. PMID: 36424240
-
The Dystonia Coalition: A Multicenter Network for Clinical and Translational Studies.Front Neurol. 2021 Apr 8;12:660909. doi: 10.3389/fneur.2021.660909. eCollection 2021. Front Neurol. 2021. PMID: 33897610 Free PMC article. Review.
-
Laryngeal Imaging Study of Glottal Attack/Offset Time in Adductor Spasmodic Dysphonia during Connected Speech.Appl Sci (Basel). 2023 Mar 1;13(5):2979. doi: 10.3390/app13052979. Epub 2023 Feb 25. Appl Sci (Basel). 2023. PMID: 37034315 Free PMC article.
-
Childhood Laryngeal Dystonia Following Bilateral Globus Pallidus Abnormality: A Case Study and Review of Literature.Iran J Otorhinolaryngol. 2017 Jan;29(90):47-52. Iran J Otorhinolaryngol. 2017. PMID: 28229063 Free PMC article.
References
-
- Sapienza CM, Walton S, Murry T. Adductor spasmodic dysphonia and muscular tension dysphonia: acoustic analysis of sustained phonation and reading. J Voice. 2000;14:502–20. - PubMed
-
- Izdebski K, Dedo HH, Boles L. Spastic dysphonia: A patient profile of 200 cases. American Journal of Otolaryngology. 1984;5:7–14. - PubMed
-
- Schweinfurth JM, Billante M, Courey MS. Risk factors and demographics in patients with spasmodic dysphonia. Laryngoscope. 2002;112:220–3. - PubMed
-
- Shipp T, Izdebski K, Reed C, et al. Intrinsic laryngeal muscle activity in a spastic dysphonic patient. Journal of Speech Hear Dis. 1985;50:54–59. - PubMed